Omega Fund Management
Overview
Omega Fund Management is a private equity firm headquartered in Boston, Massachusetts, specializing in investments within the life sciences sector. The firm focuses on supporting exceptional founders and impactful products across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Fund Management has a proven track record, having successfully brought 52 products to patients, with one public listing and eight acquisitions among the companies it has managed as an advisor to certain European funds. The firm's investment strategy encompasses a range of stages, from early-stage ventures to late-stage and pre-IPO companies, with investment sizes typically ranging from $10 million to $50 million. Omega Fund Management's geographical focus spans North America and Western Europe, including countries such as the United States, United Kingdom, Germany, France, Switzerland, and others. The firm is dedicated to fostering innovation and advancing science to improve patient outcomes through strategic investments. With a team that combines experience, commitment, and connections, Omega Fund Management aims to enhance the odds of success for entrepreneurs and founders in the biotech sector. The firm focuses on fostering innovation and advancing science to improve patient outcomes through strategic investments.
Investment Focus
- Strong management teams
- Innovative products
- Potential for significant impact in therapeutic areas
Portfolio Companies
Reach Omega Fund Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Omega Fund Management
What sectors does Omega Fund Management invest in?
Omega Fund Management invests in Healthcare, Life Sciences, Medical Devices, Biotechnology, Oncology and Precision Medicine, and is based in Massachusetts, United States. Omega Fund Management is listed as a private equity in the ConnectSafely investor database.
What stage does Omega Fund Management invest at?
Omega Fund Management backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 10M - 50M.
Which regions does Omega Fund Management invest in?
Omega Fund Management invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has Omega Fund Management invested in?
Omega Fund Management's portfolio includes Beam Therapeutics, Bluebird Bio, Moderna, Alnylam Pharmaceuticals, Editas Medicine, Sarepta Therapeutics, Intellia Therapeutics and CRISPR Therapeutics.
Last updated · Source: ConnectSafely investor database
